Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

HER2 Directed Antibody-Drug-Conjugates beyond T-DM1 in Breast Cancer.

Rinnerthaler G, Gampenrieder SP, Greil R.

Int J Mol Sci. 2019 Mar 5;20(5). pii: E1115. doi: 10.3390/ijms20051115. Review.

2.
3.

Differential susceptibility of renal carcinoma cell lines to tumor suppression by exogenous Fhit expression.

Werner NS, Siprashvili Z, Fong LY, Marquitan G, Schröder JK, Bardenheuer W, Seeber S, Huebner K, Schütte J, Opalka B.

Cancer Res. 2000 Jun 1;60(11):2780-5.

4.
5.

Improving physicians' and nurses' clinical breast examination: a randomized controlled trial.

Campbell HS, Fletcher SW, Pilgrim CA, Morgan TM, Lin S.

Am J Prev Med. 1991 Jan-Feb;7(1):1-8.

PMID:
1867894

Supplemental Content

Loading ...
Support Center